Top compounds associated with response to PIWIL4


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.3 6e-19
mRNA linifanib GDSC1000 pan-cancer AAC 0.31 1e-16
mRNA AC220 GDSC1000 pan-cancer AAC 0.29 4e-15
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-11
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.23 7e-10
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.2 1e-09
mRNA PD318088 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA AZD6244 CCLE pan-cancer AAC 0.27 3e-09
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA Sorafenib CCLE pan-cancer AAC 0.28 4e-09
Download CSV